Found: 21
Select item for more details and to access through your institution.
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 12, p. 2644, doi. 10.3390/cells9122644
- By:
- Publication type:
- Article
The Landscape of Actionable Gene Fusions in Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5319, doi. 10.3390/ijms20215319
- By:
- Publication type:
- Article
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231204857
- By:
- Publication type:
- Article
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231165978
- By:
- Publication type:
- Article
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221108687
- By:
- Publication type:
- Article
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079123
- By:
- Publication type:
- Article
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006960
- By:
- Publication type:
- Article
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006960
- By:
- Publication type:
- Article
Clinical Behavior and Treatment Response of Epstein‐Barr Virus‐Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 780, doi. 10.1634/theoncologist.2020-0037
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e17, doi. 10.1016/j.cllc.2021.06.013
- By:
- Publication type:
- Article
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
- Published in:
- Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920946693
- By:
- Publication type:
- Article
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
- Published in:
- Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920946693
- By:
- Publication type:
- Article
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006960
- By:
- Publication type:
- Article
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920970081
- By:
- Publication type:
- Article
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.925551
- By:
- Publication type:
- Article
The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)—Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1964, doi. 10.3390/cancers13081964
- By:
- Publication type:
- Article
Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 617, doi. 10.3390/cancers12030617
- By:
- Publication type:
- Article
Adding fasting‐mimicking diet to first‐line carboplatin‐based chemotherapy is associated with better overall survival in advanced triple‐negative breast cancer patients: A subanalysis of the NCT03340935 trial.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 1, p. 114, doi. 10.1002/ijc.34701
- By:
- Publication type:
- Article
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00534-1
- By:
- Publication type:
- Article
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State.
- Published in:
- Small, 2022, v. 18, n. 48, p. 1, doi. 10.1002/smll.202206567
- By:
- Publication type:
- Article
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State.
- Published in:
- Small, 2022, v. 18, n. 17, p. 1, doi. 10.1002/smll.202106097
- By:
- Publication type:
- Article